CN Patent

CN104803906A — 化合物及其制备方法和用途

Assigned to Nanjing Xin Weifang Pharmaceutical Technology Co Ltd · Expires 2015-07-29 · 11y expired

What this patent protects

本发明属于医药技术领域，具体涉及一种(+)-2-[1-(3-乙氧基-4-甲氧苯基)-2-甲磺酰基乙基]-4-乙酰氨基异吲哚啉-1，3-二酮的化学结构类似物及其制备方法，该化合物可以作为(+)-2-[1-(3-乙氧基-4-甲氧苯基)-2-甲磺酰基乙基]-4-乙酰氨基异吲哚啉-1，3-二酮的质量控制标准品。

USPTO Abstract

本发明属于医药技术领域，具体涉及一种(+)-2-[1-(3-乙氧基-4-甲氧苯基)-2-甲磺酰基乙基]-4-乙酰氨基异吲哚啉-1，3-二酮的化学结构类似物及其制备方法，该化合物可以作为(+)-2-[1-(3-乙氧基-4-甲氧苯基)-2-甲磺酰基乙基]-4-乙酰氨基异吲哚啉-1，3-二酮的质量控制标准品。

Drugs covered by this patent

Patent Metadata

Patent number
CN104803906A
Jurisdiction
CN
Classification
—
Expires
2015-07-29
Drug substance claim
No
Drug product claim
No
Assignee
Nanjing Xin Weifang Pharmaceutical Technology Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.